Estudio del líquido cefalorraquídeo en pacientes con neoplasias hematológicas malignas

Alain Areces-López

Texto completo:

PDF

Resumen

 

Introducción: La infiltración del sistema nervioso central por células malignas constituye una complicación grave de algunas neoplasias hematológicas, principalmente leucemias agudas y linfomas agresivos.

 

Objetivo: Resumir la base científica y la significación clínica de los métodos de estudio del líquido cefalorraquídeo para el diagnóstico y el seguimiento de la infiltración neuromeníngea en pacientes con neoplasias hematológicas.

 

Métodos: Se buscó información durante abril de 2021 en las bases de datos PubMed, ScienceDirect y SciELO. Se seleccionaron las publicaciones en base a su tipología, actualidad, alcance y las limitaciones de los estudios.

 

Conclusiones: El estudio citomorfológico del líquido cefalorraquídeo se considera el método estándar para el diagnóstico y el seguimiento de la infiltración neuromeníngea. La citometría de flujo resulta más sensible para la detección de infiltración oculta que la citología convencional; pero aún existen reservas sobre su significación clínica. Se investiga también la sensibilidad de otros estudios moleculares como el uso de la reacción en cadena de la polimerasa y la detección de biomarcadores.


Palabras clave

biomarcadores; citometría de flujo; neoplasias hematológicas; líquido cefalorraquídeo; reacción en cadena de la polimerasa; sistema nervioso central.

Referencias

Pui CH, Thiel E. Central nervous system disease in hematologic malignancies: historical perspective and practical applications. Sem Oncology. 2009;36(supl 2):S2-16. DOI: https://doi.org/10.1053/j.seminoncol.2009.05.002

Mauermann ML. Neurologic complications of lymphoma, leukemia, and paraproteinemias. Continuum (Minneap Minn). 2017;23(3):669-90. DOI: https://doi.org/10.1212/con.0000000000000468

Girard S, Fenneteau O, Mestrallet F, Troussard X, Lesesve JF. Recommendations for cerebrospinal fluid examination in acute leukemia. Ann Biol Clin. 2017;75(5):503-12. DOI: https://doi.org/10.1684/abc.2017.1250

Lenk L, Alsadeq A, Schewe DM. Involvement of the central nervous system in acute lymphoblastic leukemia: opinions on molecular mechanisms and clinical implications based on recent data. Cancer Metastasis Rev. 2020;39(1):173-87. DOI: https://doi.org/10.1007/s10555-020-09848-z

Deak D, Gorcea-Andronic N, Sas V, Teodorescu P, Constantinescu C, Iluta S, et al. A narrative review of central nervous system involvement in acute leukemias. Ann Transl Med. 2021;9(1):68. DOI: https://doi.org/10.21037/atm-20-3140

Thastrup M, Marquart HV, Levinsen M, Grell K, Abrahamsson J, Albertsen BK, et al. Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: A Nordic Society of Pediatric Hematology and Oncology study. Leukemia. 2020;34(2):336-46. DOI: https://doi.org/10.1038/s41375-019-0570-1

Yousafzai YM, Smith L, Smith A, Bhatti S, Gardiner M, Cousins A, et al. Use of quantitative polymerase chain reaction (qPCR) for the diagnosis and monitoring of CNS leukaemia. Leuk Res. 2019;87:106232. DOI: https://doi.org/10.1016/j.leukres.2019.106232

Ikonomidou C. Cerebrospinal fluid biomarkers in childhood leukemias. Cancers. 2021;13(3):438. DOI: https://doi.org/10.3390/cancers13030438

Frishman L, Izraeli S. Advances in understanding the pathogenesis of CNS acute lymphoblastic leukaemia and potential for therapy. Br J Haematol. 2017;176(2):157-67. DOI: https://doi.org/10.1111/bjh.14411

Yao H, Price TT, Cantelli G, Ngo B, Warner MJ, Olivere L, et al. Leukaemia hijacks a neural mechanism to invade the central nervous system. Nature. 2018;560(7716):55-60. DOI: https://doi.org/10.1038/s41586-018-0342-5

Zhou F, Wen Y, Jin R, Chen H. New attempts for central nervous infiltration of pediatric acute lymphoblastic leukemia. Cancer Metastasis Rev. 2019;38(4):657-71. DOI: https://doi.org/10.1007/s10555-019-09827-z

Del Principe MI, Buccisano F, Soddu S, Maurillo L, Cefalo M, Piciocchi A, et al. Involvement of central nervous system in adult patients with acute myeloid leukemia: Incidence and impact on outcome. Semin Hematol. 2018;55(4):209-14. DOI: https://doi.org/10.1053/j.seminhematol.2018.02.006

Hernández CC, Pino LSM, García GA, Carnot UJ, Muñío PJ, Cepero LK; et al. Caracterización de los linfomas no Hodgkin con afectación del sistema nervioso. Rev Acta Méd. 2018 [acceso 05/04/2021];19(3). Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=84187

Villegas CA, Suárez A, Torres G, González T, Martínez LY, Gracia EA, et al. Supervivencia de pacientes con linfoma no-Hodgkin y síntomas neurológicos según inmunofenotipo del líquido cefalorraquídeo. Rev Cub Hematol Inmunol Hemoter. 2019 [acceso 05/04/2021];35(3):e1068. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892019000300008

Murthy H, Anasetti C, Ayala E. Diagnosis and management of leukemic and lymphomatous meningitis. Cancer Control. 2017;24(1):33-41. DOI: https://doi.org/10.1177/107327481702400105

Bassan R, Maino E, Cortelazzo S. Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment. Eur J Haematol. 2016;96(5):447-60. DOI: https://doi.org/10.1111/ejh.12722

Barredo J, Ritchey AK. Controversies in the management of central nervous system leukemia. Pediatr Hematol Oncol. 2010;27(5):329-32. DOI: https://doi.org/10.3109/08880011003758422

Yeh TC, Liang DC, Hou JY, Jaing TH, Lin DT, Yang CP, et al. Treatment of childhood acute lymphoblastic leukemia with delayed first intrathecal therapy and omission of prophylactic cranial irradiation: Results of the TPOG-ALL-2002 study. Cancer. 2018;124(23):4538-47. DOI: https://doi.org/10.1002/cncr.31758

Wu JM, Georgy MF, Burroughs FH, Weir EG, Rosenthal DL, Ali SZ. Lymphoma, leukemia, and pleiocytosis in cerebrospinal fluid: is accurate cytopathologic diagnosis possible based on morphology alone? Diagn Cytopathol. 2009;37(11):820-4. DOI: https://doi.org/10.1002/dc.21110

Crespo E, López X, Higuera J, Vega B. Diagnosis of acute leukemia in cerebrospinal fluid (CSF-acute leukemia). Curr Oncol Rep. 2012;14(5):369-78. DOI: https://doi.org/10.1007/s11912-012-0248-6

Rahimi J, Woehrer A. Overview of cerebrospinal fluid cytology. Handb Clin Neurol. 2017;145:563-71. DOI: https://doi.org/10.1016/B978-0-12-802395-2.00035-3

Pui CH, Howard SC. Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol. 2008;9(3):257-68. DOI: https://doi.org/10.1016/S1470-2045(08)70070-6

Seo JY, Lee SH, Kim HJ, Yoo KH, Koo HH, Cho YG, et al. MYC rearrangement involving a novel non-immunoglobulin chromosomal locus in precursor B-cell acute lymphoblastic leukemia. Ann Lab Med. 2012;32(4):289-93. DOI: https://doi.org/10.3343/alm.2012.32.4.289

Canovi S, Campioli D. Accuracy of flow cytometry and cytomorphology for the diagnosis of meningeal involvement in lymphoid neoplasms: A systematic review. Diagn Cytopathol. 2016;44(10):841-56. DOI: https://doi.org/10.1002/dc.23539

Jaime JC, Borrego MF, Jiménez RA, Méndez N, Salazar R, Fernández LT, et al. Comparison of conventional cytomorphology, flow cytometry immunophenotyping, and automated cell counting of CSF for detection of CNS involvement in acute lymphoblastic leukemia. Int J Lab Hematol. 2018;40(2):169-74. DOI: https://doi.org/10.1111/ijlh.12760

Debliquis A, Voirin J, Harzallah I, Maurer M, Lerintiu F, Drénou B, et al. Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B-cell lymphoma of the central nervous system. Cytometry B Clin Cytom. 2018;94(1):182-8. DOI: https://doi.org/10.1002/cyto.b.21403

Gajjar A, Harrison PL, Sandlund JT, Rivera GK, Ribeiro RC, Rubnitz JE. Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. Blood. 2000;96(10):3381-4. DOI: https://doi.org/10.1182/blood.V96.10.3381

Triana Y, Marsán V. Aplicaciones de la citometría de flujo en el estudio de los síndromes linfoproliferativos crónicos. Rev Cub Hematol Inmunol Hemoter. 2020 [acceso 18/04/2021];36(1):e1137. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0864-02892020000100002&script=sci_arttext&tlng=en

Mitri Z, Siddiqui MT, El Rassi F, Holden JT, Heffner LT, Langston A, et al. Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphoma. Leuk Lymphoma. 2014;55(7):1498-500. DOI: https://doi.org/10.3109/10428194.2013.852667

Babusíková O, Zelezníková T. The value of multiparameter flow cytometry of cerebrospinal fluid involved by leukemia/lymphoma cells. Neoplasma. 2004 [acceso 18/04/2021];51(5):345-51. Disponible en: https://pubmed.ncbi.nlm.nih.gov/15640938

Del Principe MI, Buzzatti E, Piciocchi A, Forghieri F, Bonifacio M, Lessi F, et al. Clinical significance of occult central nervous system disease in adult acute lymphoblastic leukemia. A multicenter report from the Campus ALL Network. Haematol. 2021;106(1):39-45. DOI: https://doi.org/10.3324/haematol.2019.231704

Egan PA, Elder PT, Deighan WI, O'Connor SJM, Alexander HD. Multiple myeloma with central nervous system relapse. Haematol. 2020;105(7):1780-90. DOI: https://doi.org/10.3324/haematol.2020.248518

Dias AL, Higashi F, Peres ALM, Cury P, Crusoé EQ, Hungria VTM. Multiple myeloma and central nervous system involvement: experience of a Brazilian center. Rev Bras Hematol Hemoter. 2018;40(1):30-6. DOI: https://doi.org/10.1016/j.bjhh.2017.09.004

Ren H, Zou Y, Zhao Y, Li J, Han X, He J, et al. Cerebrospinal fluid cytological diagnosis in multiple myeloma with leptomeningeal involvement: a report of two cases. Diagn Cytopathol. 2017;45(1):66-8. DOI: https://doi.org/10.1002/dc.23600

Popov A, Henze G, Verzhbitskaya T, Roumiantseva J, Lagoyko S, Khlebnikova O, et al. Absolute count of leukemic blasts in cerebrospinal fluid as detected by flow cytometry is a relevant prognostic factor in children with acute lymphoblastic leukemia. J Cancer Res Clin Oncol. 2019;145:1331-9. DOI: https://doi.org/10.1007/s00432-019-02886-3

Pine SR, Yin C, Matloub YH, Sabaawy HE, Sandoval C, Levendoglu-Tugal O, et al. Detection of central nervous system leukemia in children with acute lymphoblastic leukemia by real-time polymerase chain reaction. J Molec Diag. 2005;7(1):127-32. DOI: https://doi.org/10.1016/S1525-1578(10)60018-9

Scrideli CA, Queiroz RP, Takayanagui OM, Bernardes JE, Tone LG. Polymerase chain reaction on cerebrospinal fluid cells in suspected leptomeningeal involvement in childhood acute lymphoblastic leukemia: comparison to cytomorphological analysis. Diagn Mol Pathol. 2003;12(3):124-7. DOI: https://doi.org/10.1097/00019606-200309000-00002

Cancela CSP, Assumpcao JG, Paula FDF, Murao M, Viana MB, Oliveira BM. Use of the polymerase chain reaction as a complementary method for the detection of central nervous system involvement in children and adolescents with acute lymphoblastic leukemia. Clin Lab. 2018;64(1):205-9. DOI: https://doi.org/10.7754/clin.lab.2017.170622

Gajendra S, Das RR, Sharma R. Isolated central nervous system (CNS) relapse in paediatric acute promyelocytic leukaemia: A systematic review. J Clin Diagn Res. 2017;11(3):XE05-8. DOI: https://doi.org/10.7860/JCDR/2017/24196.9572

Biojone E, Queiróz P, Valera ET, Odashima NS, Takayanagui OM, Viana MB, et al. Minimal residual disease in cerebrospinal fluid at diagnosis: a more intensive treatment protocol was able to eliminate the adverse prognosis in children with acute lymphoblastic leukemia. Leuk Lympho. 2012;53(1):89-95. DOI: https://doi.org/10.3109/10428194.2011.606939

Xiao F, Lv S, Zong Z, Wu L, Tang X, Kuang W, et al. Cerebrospinal fluid biomarkers for brain tumor detection: clinical roles and current progress. Am J Transl Res. 2020 [acceso 18/04/2021];12(4):1379-96. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32355549

Kopková A, Šána J, Večeřa M, Fadrus P, Lipina R, Smrčka M, et al. MicroRNAs in cerebrospinal fluid as biomarkers in brain tumor patients. Klin Onkol. 2019;32(3):181-6. DOI: https://doi.org/10.14735/amko2019181

Mikhael NL, Seif MA, Hassab H, Megahed EA. Evaluation of multiplexed biomarkers in assessment of CSF infiltration in pediatric acute lymphoblastic leukemia. Int J Hematol Oncol. 2019;8(3). DOI: https://doi.org/10.2217/ijh-2019-0008



Licencia de Creative Commons
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.